Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Civatech Oncology in September, 2017 for $2,034,620.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA210770-02 | Phase II | 2,034,620 | September 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Civatech Oncology in September, 2016 for $299,599.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA210770-01 | Phase I | 299,599 | September 13, 2016 | |||||||
A SBIR Phase I contract was awarded to Civatech Oncology in September, 2017 for $296,866.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA217587-01 | Phase I | 296,866 | September 15, 2017 | |||||||
A SBIR Phase II contract was awarded to Civatech Oncology for $998,964.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CO120052 | Phase II | 998,964 | ||||||||
A SBIR Phase I contract was awarded to Civatech Oncology for $199,266.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO201000081 | Phase I | 199,266 | ||||||||
A SBIR Phase II contract was awarded to Civatech Oncology in July, 2023 for $1,864,846.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA210770-04A1 | Phase II | 1,864,846 | July 8, 2023 |